Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (241-250 of 1,858) with videos related to

Pageof 186
Sort By:
Cardiology in Review|April 23, 2019
Angiopoietin-Like 3 Protein Inhibition: A New Frontier in Lipid-Lowering TreatmentWilliam Lang, William H Frishman
Progress in Biophysics and Molecular Biology|August 14, 1999
Genome-based structural biologyD Frishman, H W Mewes
Journal of Clinical Pharmacology|April 17, 2001
Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic targetS Sinha, W H Frishman
Cardiology in Review|December 8, 2010
Soluble guanylate cyclase activation with cinaciguat: a new approach to the treatment of decompensated heart failureShipra Hingorany, William H Frishman
Cardiology in Review|October 8, 2010
Relaxin: a new approach for the treatment of acute congestive heart failureJason Grossman, William H Frishman
Cardiology in Review|December 7, 2011
Vitamin D: a cardioprotective agent?Yaakov Liss, William H Frishman
Cardiology in Review|February 2, 2012
Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemiaDaniel N Ricotta, William Frishman
Journal of Clinical Pharmacology|March 1, 1990
Rapid-acting parenteral antihypertensive agentsG Chun, W H Frishman
Investigative Ophthalmology & Visual Science|September 28, 2011
Retinal pathway origins of the pattern electroretinogram (PERG)Xunda Luo, Laura J Frishman
American Journal of Therapeutics|April 1, 1995
Ranolazine: A New Anti-Ischemic Drug Which Affects Myocardial EnergeticsMarc Goldschmidt, William H. Frishman
Pageof 186

Showing results (241-250 of 1,858) with videos related to

Sort By:
Pageof 186
Cardiology in Review|April 23, 2019
Angiopoietin-Like 3 Protein Inhibition: A New Frontier in Lipid-Lowering TreatmentWilliam Lang, William H Frishman
Progress in Biophysics and Molecular Biology|August 14, 1999
Genome-based structural biologyD Frishman, H W Mewes
Journal of Clinical Pharmacology|April 17, 2001
Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic targetS Sinha, W H Frishman
Cardiology in Review|December 8, 2010
Soluble guanylate cyclase activation with cinaciguat: a new approach to the treatment of decompensated heart failureShipra Hingorany, William H Frishman
Cardiology in Review|October 8, 2010
Relaxin: a new approach for the treatment of acute congestive heart failureJason Grossman, William H Frishman
Cardiology in Review|December 7, 2011
Vitamin D: a cardioprotective agent?Yaakov Liss, William H Frishman
Cardiology in Review|February 2, 2012
Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemiaDaniel N Ricotta, William Frishman
Journal of Clinical Pharmacology|March 1, 1990
Rapid-acting parenteral antihypertensive agentsG Chun, W H Frishman
Investigative Ophthalmology & Visual Science|September 28, 2011
Retinal pathway origins of the pattern electroretinogram (PERG)Xunda Luo, Laura J Frishman
American Journal of Therapeutics|April 1, 1995
Ranolazine: A New Anti-Ischemic Drug Which Affects Myocardial EnergeticsMarc Goldschmidt, William H. Frishman
Pageof 186